Works matching AU Jin-Seok Kim
Results: 280
Rapid Emergence and Clonal Dissemination of CTX-M-15-Producing Salmonella enterica Serotype Virchow, South Korea.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Identification of Markers Associated With Development of Stroke in "Clinically Low-Risk" Atrial Fibrillation Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prevalence of Isolated Nocturnal Hypertension and Development of Arterial Stiffness, Left Ventricular Hypertrophy, and Silent Cerebrovascular Lesions: The KoGES (Korean Genome and Epidemiology Study).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00375-2
- By:
- Publication type:
- Article
Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0245-1
- By:
- Publication type:
- Article
Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS‐SPAF).
- Published in:
- Journal of Arrhythmia, 2023, v. 39, n. 3, p. 376, doi. 10.1002/joa3.12840
- By:
- Publication type:
- Article
Real‐world data for the use of emicizumab in haemophilia A patients with inhibitors – First nationwide report from Korea.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1163, doi. 10.1111/hae.14819
- By:
- Publication type:
- Article
Clinical characteristics and prognostic factors of acquired haemophilia A in Korea.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e609, doi. 10.1111/hae.14370
- By:
- Publication type:
- Article
Epidemiological Characteristics of Scrub Typhus in Korea, 2009
- Published in:
- Osong Public Health & Research Perspectives, 2010, v. 1, n. 1, p. 55, doi. 10.1016/j.phrp.2010.12.012
- By:
- Publication type:
- Article
Trends in Water- and Foodborne Disease Outbreaks in Korea, 2007–2009
- Published in:
- Osong Public Health & Research Perspectives, 2010, v. 1, n. 1, p. 50, doi. 10.1016/j.phrp.2010.12.011
- By:
- Publication type:
- Article
Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e360, doi. 10.1016/j.clml.2023.06.011
- By:
- Publication type:
- Article
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e751, doi. 10.1016/j.clml.2022.04.005
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 545, doi. 10.1016/j.clml.2022.03.011
- By:
- Publication type:
- Article
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. 89, doi. 10.1016/j.clml.2021.08.005
- By:
- Publication type:
- Article
P-198: Isatuximab plus Carfilzomib and Dexamethasone in East Asian patients with relapsed Multiple Myeloma: IKEMA subgroup analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S146, doi. 10.1016/S2152-2650(21)02325-9
- By:
- Publication type:
- Article
P-137: ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S109, doi. 10.1016/S2152-2650(21)02264-3
- By:
- Publication type:
- Article
Analysis of the Efficacy of Thalidomide Plus Dexamethasone-Based Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Received Prior Chemotherapy, Including Bortezomib and Lenalidomide: KMM-166 Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Prospective, Multicenter Phase II Study of Consolidation with Cyclophosphamide, Bortezomib and Dexamethasone (CVD) in Patients with Multiple Myeloma after Autologous Stem Cell Transplantation; The KMM130 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e291, doi. 10.1016/j.clml.2019.09.478
- By:
- Publication type:
- Article
Analysis of Efficacy and Predictive Factors for Treatment Response of Thalidomide-Containing Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Prior Chemotherapy Including Bortezomib and Lenalidomide.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e69, doi. 10.1016/j.clml.2017.03.125
- By:
- Publication type:
- Article
Daratumumab, Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM Based on Prior Lines and Treatment Exposure: POLLUX.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e116, doi. 10.1016/j.clml.2017.03.211
- By:
- Publication type:
- Article
Bortezomib-Melphalan-Prednisone (VMP) Versus MP as Initial Treatment for Very Elderly Patients With Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e70, doi. 10.1016/j.clml.2017.03.126
- By:
- Publication type:
- Article
Phase 2 Study Using Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma; Final Analysis (KMM150).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e73, doi. 10.1016/j.clml.2017.03.133
- By:
- Publication type:
- Article
The Efficacy and Safety of Lenalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma in Real Clinical Practice : A Study of the Korean Multiple Myeloma Working Party (KMMWP).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e74, doi. 10.1016/j.clml.2017.03.135
- By:
- Publication type:
- Article
Clinical Features and Results of Bortezomib-Melphalan-Prednisone (VMP) as Initial Treatment in Elderly Multiple Myeloma Patients Received Lenalidomide with Dexamethasone (Len/Dex): Subgroup Analysis of Lenalidomide Registry from Korean Multiple Myeloma Working Party (KMM151)
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e129, doi. 10.1016/j.clml.2017.03.233
- By:
- Publication type:
- Article
Depth of Response and MRD with Daratumumab Plus Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM: POLLUX.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e17, doi. 10.1016/j.clml.2017.03.029
- By:
- Publication type:
- Article
The outcomes of Korean Patients With Primary Plasma Cell Leukemia: Analysis of Korean Multiple Myeloma Working Party (KMM160).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e38, doi. 10.1016/j.clml.2017.03.067
- By:
- Publication type:
- Article
A prognostic Scoring System for Patients With Multiple Myeloma Who Were Classified Stage II by Revised International Staging System.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e39, doi. 10.1016/j.clml.2017.03.068
- By:
- Publication type:
- Article
Visualization of gaseous and dissolved CO<sub>2</sub> migration in porous media.
- Published in:
- Environmental Earth Sciences, 2018, v. 77, n. 8, p. 1, doi. 10.1007/s12665-018-7484-5
- By:
- Publication type:
- Article
Primary Thyroid Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type: Clinical Manifestation and Outcome of a Rare Disease - Consortium for Improving Survival of Lymphoma Study.
- Published in:
- Acta Haematologica, 2012, v. 127, n. 2, p. 100, doi. 10.1159/000333113
- By:
- Publication type:
- Article
Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry.
- Published in:
- Acta Haematologica, 2009, v. 122, n. 4, p. 200, doi. 10.1159/000253027
- By:
- Publication type:
- Article
Transfusion-Associated Iron Overload as an Adverse Risk Factor for Transplantation Outcome in Patients Undergoing Reduced-Intensity Stem Cell Transplantation for Myeloid Malignancies.
- Published in:
- Acta Haematologica, 2009, v. 120, n. 3, p. 182, doi. 10.1159/000187646
- By:
- Publication type:
- Article
Strains related to 'Candidatus Phytoplasma ulmi'- are associated with Chinese Elm yellows in Korea.
- Published in:
- Journal of Plant Pathology, 2021, v. 103, n. 4, p. 1339, doi. 10.1007/s42161-021-00912-3
- By:
- Publication type:
- Article
research paper Apicidin potentiates the imatinib-induced apoptosis of Bcr–Abl-positive human leukaemia cells by enhancing the activation of mitochondria-dependent caspase cascades.
- Published in:
- British Journal of Haematology, 2004, v. 124, n. 2, p. 166, doi. 10.1046/j.1365-2141.2003.04759.x
- By:
- Publication type:
- Article
Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype.
- Published in:
- British Journal of Haematology, 2002, v. 118, n. 4, p. 1128, doi. 10.1046/j.1365-2141.2002.03767.x
- By:
- Publication type:
- Article
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 6, p. 1989, doi. 10.1007/s00277-023-05603-w
- By:
- Publication type:
- Article
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 863, doi. 10.1007/s00277-023-05090-z
- By:
- Publication type:
- Article
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2051, doi. 10.1007/s00277-021-04407-0
- By:
- Publication type:
- Article
Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 9, p. 2149, doi. 10.1007/s00277-020-04043-0
- By:
- Publication type:
- Article
Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical implication of renal dysfunction during the clinical course in patients with paroxysmal nocturnal hemoglobinuria: a longitudinal analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.
- Published in:
- 2016
- By:
- Publication type:
- journal article